TY  - GEN
AU  - Sciot,Raf
AU  - Debiec-Rychter,Maria
AU  - Daugaard,Soren
AU  - Fisher,Cyril
AU  - Collin,Francoise
AU  - van Glabbeke,Martine
AU  - Verweij,Jaap
AU  - Blay,Jean-Yves
AU  - Hogendoorn,Pancras C W
TI  - Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate
SN  - 1879-0852
PY  - 2008///1210
KW  - Antigens, CD34
KW  - metabolism
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Benzamides
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Exons
KW  - Female
KW  - Gastrointestinal Stromal Tumors
KW  - drug therapy
KW  - Humans
KW  - Imatinib Mesylate
KW  - Immunohistochemistry
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Mutation
KW  - genetics
KW  - Piperazines
KW  - Proto-Oncogene Proteins c-kit
KW  - Pyrimidines
KW  - Receptor, Platelet-Derived Growth Factor alpha
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.ejca.2008.06.003
ER  -